This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Liver Transplant; Complications

High Versus Low Blood-Pressure Target in the Post Operative Care of Liver Transplantation A Randomized, Controled, Open and Unicentric Trial.

Sponsored by University of Sao Paulo General Hospital

About this trial

Last updated 2 years ago

Study ID

LIVER-PAM

Status

Recruiting

Type

Interventional

Phase

Phase 3

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

LIVER PAM A randomized, controled, open and unicentric trial comparing high (MAP 85-90 mmHg) and low (65-70 mmHg) target of mean arterial pressure in the first 24 hours after liver transplantation.

What are the participation requirements?

Yes

Inclusion Criteria

- Older than 18 y

- Admitted in the ICU for a post operative care after liver transplant

No

Exclusion Criteria

- Consent refusal

- Liver transplant due to acute liver failure

- Renal transplant ( Previous or concomitant)

- Refusal from the healthcare provider responsible for the patient

- Renal substitution therapy in the prior 15 days

- Pregnancy

- Re-Transplant (Liver transplant in the previous 6 month)

- Hepatorenal syndrome current treatment (Use of terlipressin + Albumin)

- Refractory and persistent shock during or after transplant

Locations

Location

Status

Recruiting